EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment induced changes of bone density and relative risk of vertebral fracture



Treatment induced changes of bone density and relative risk of vertebral fracture



Journal of Endocrinological Investigation 22(8): 609-615



For the purpose of achieving gene transfer into cells mediated by peptides with a short chain length, we employed two kinds of amphiphilic alpha-helix peptides, mastoparan (INLK-ALAA-LAKK-IL-NH2) obtained from wasp venom and an alpha-helix model peptide (LARL-LARL-LARL-NH2). Furthermore, to strengthen the hydrophobicity of the peptide required for the formation of the aggregates with the DNA, we modified these peptides using several lipophilic groups, i.e. acyl groups with a single chain, a dialkylcarbamoyl group and a cholesteryloxycarbonyl group. We examined the ability of the peptides and their derivatives to bind and aggregate with plasmid DNA, the structural change in the peptides caused by binding with the DNA and the in vitro gene transfer abilities into COS-7 cells. As a result, mastoparan was found to acquire the DNA binding ability by introduction of the lipophilic group. The conformational change in the peptides depended on the hydrophobicity of the introduced acyl group. The DNA complex of most lipophilic mastoparan derivatives could be incorporated into the cells via the endocytosis pathway. In the case of the helix model peptide, the acyl group with a moderate chain length was required for the formation of the aggregate which is competent for incorporation into the cells. In this study, we succeeded in giving such short peptides sufficient gene transfer ability by modifying them with some lipophilic groups. However, the influence of the modification by the lipophilic groups on the formation of aggregates with DNA and the gene transfer ability depended on the structure of the peptide portion. These results indicate that consideration of total hydrophobicity balance is needed for the design of an efficient gene carrier peptide.

(PDF same-day service: $19.90)

Accession: 035980267

Download citation: RISBibTeXText

PMID: 10532248

DOI: 10.1007/BF03343618



Related references

Relationship of changes in total hip bone mineral density to vertebral and non-vertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5?mg the HORIZON-Pivotal Fracture Trial PFT. 2012

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. Journal of Clinical Densitometry 7(3): 255-261, 2004

Usefulness of Fracture Risk Assessment Tool Using Lumbar Bone Mineral Density in Prediction of Osteoporotic Vertebral Fracture. Journal of Korean Neurosurgical Society 58(4): 346-349, 2015

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24): 2077-2082, 1999

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture interventional trial. JAMA (Journal of the American Medical Association) 280(24): 2077-2082, Dec 23-30, 1998

Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clinic Proceedings 80(3): 343-349, 2005

Combined vertebral fracture assessment and bone mineral density measurement: a patient-friendly new tool with an important impact on the Canadian Risk Fracture Classification. Canadian Association of Radiologists Journal 61(4): 194-200, 2010

Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide. Current Medical Research and Opinion 30(5): 931-936, 2014

High prevalence of spine–femur bone mineral density discordance and comparison of vertebral fracture risk assessment using femoral neck and lumbar spine bone density in Korean patients. Journal of Bone and Mineral Metabolism 32(4): 405-410, 2015

Relationship between phalangeal bone density and risk of vertebral fracture. Journal of Clinical Densitometry 5(1): 11-15, 2002

Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Human Molecular Genetics 12(14): 1745-1754, 2003

Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have vertebral fracture assessment. Osteoporosis International 21(12): 2083-2091, 2011

No-vertebral fracture rates are lower in Hong Kong Chinese men than American Caucasians but bone mineral density predicts fracture risk similarly in the 2 groups-results from Mr Os international. 2007